Betty Weert

1.0k total citations
22 papers, 893 citations indexed

About

Betty Weert is a scholar working on Oncology, Hepatology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Betty Weert has authored 22 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Hepatology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Betty Weert's work include Drug Transport and Resistance Mechanisms (11 papers), Liver physiology and pathology (9 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Betty Weert is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Liver physiology and pathology (9 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Betty Weert collaborates with scholars based in Netherlands, Germany and United States. Betty Weert's co-authors include Dirk K. F. Meijer, Klaas Poelstra, Leonie Beljaars, Johan W. Smit, Peter Olinga, Albert Geerts, Geny M. M. Groothuis, G. A. Vermeer, Grietje Molema and Alfred H. Schinkel and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Betty Weert

21 papers receiving 875 citations

Peers

Betty Weert
Paul G. Killenberg United States
Mariska Geuken Netherlands
R Enat Israel
Montgomery D. Bissell United States
Thomas C. Knauss United States
Betty Weert
Citations per year, relative to Betty Weert Betty Weert (= 1×) peers Alie de Jager-Krikken

Countries citing papers authored by Betty Weert

Since Specialization
Citations

This map shows the geographic impact of Betty Weert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Betty Weert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Betty Weert more than expected).

Fields of papers citing papers by Betty Weert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Betty Weert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Betty Weert. The network helps show where Betty Weert may publish in the future.

Co-authorship network of co-authors of Betty Weert

This figure shows the co-authorship network connecting the top 25 collaborators of Betty Weert. A scholar is included among the top collaborators of Betty Weert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Betty Weert. Betty Weert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Melgert, Barbro N., Betty Weert, Huub Schellekens, Dirk K. F. Meijer, & Klaas Poelstra. (2003). The Pharmacokinetic and Biological Activity Profile of Dexamethasone Targeted to Sinusoidal Endothelial and Kupffer Cells. Journal of drug targeting. 11(1). 1–10. 20 indexed citations
2.
Beljaars, Leonie, Betty Weert, Albert Geerts, Dirk K. F. Meijer, & Klaas Poelstra. (2003). The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue. Biochemical Pharmacology. 66(7). 1307–1317. 87 indexed citations
3.
Melgert, Barbro N., Peter Olinga, Betty Weert, et al.. (2001). Cellular distribution and handling of liver-targeting preparations in human livers studied by a liver lobe perfusion.. PubMed. 29(4 Pt 1). 361–7. 7 indexed citations
4.
Melgert, Barbro N., Peter Olinga, Betty Weert, et al.. (2001). Targeting dexamethasone to Kupffer cells: Effects on liver inflammation and fibrosis in rats. Hepatology. 34(4). 719–728. 98 indexed citations
5.
Beljaars, Leonie, Grietje Molema, Detlef Schuppan, et al.. (2000). Successful Targeting to Rat Hepatic Stellate Cells Using Albumin Modified with Cyclic Peptides That Recognize the Collagen Type VI Receptor. Journal of Biological Chemistry. 275(17). 12743–12751. 120 indexed citations
6.
Beljaars, Leonie, Grietje Molema, Betty Weert, et al.. (1999). Albumin Modified With Mannose 6–Phosphate: A Potential Carrier for Selective Delivery of Antifibrotic Drugs to Rat and Human Hepatic Stellate Cells. Hepatology. 29(5). 1486–1493. 120 indexed citations
7.
Melgert, Barbro N., Betty Weert, Grietje Molema, Dirk K. F. Meijer, & Klaas Poelstra. (1999). Chronic treatment of bile duct ligated rats with dexamethasone selectively delivered to Kupffer cells. European Journal of Gastroenterology & Hepatology. 11(12). 110–110. 1 indexed citations
8.
Beljaars, Leonie, Klaas Poelstra, Betty Weert, et al.. (1998). The development of novel albumin carriers to hepatic stellate cells by application of cyclopeptide moieties recognizing collagen type VI and platelet derived growth factor receptors.. Data Archiving and Networked Services (DANS). 1 indexed citations
9.
Smit, Johan W., Alfred H. Schinkel, Michael Müller, Betty Weert, & Dirk K. F. Meijer. (1998). Contribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an mdr1a gene disruption. Hepatology. 27(4). 1056–1063. 70 indexed citations
10.
Smit, Johan W., Alfred H. Schinkel, Betty Weert, & Dirk K. F. Meijer. (1998). Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice in which both mdr1a and mdr1b genes have been disrupted. British Journal of Pharmacology. 124(2). 416–424. 65 indexed citations
11.
Smit, Johan W., et al.. (1998). Heterologous Expression of Various P-Glycoproteins in Polarized Epithelial Cells Induces Directional Transport of Small (Type 1) and Bulky (Type 2) Cationic Drugs. Journal of Pharmacology and Experimental Therapeutics. 286(1). 321–327. 34 indexed citations
12.
Smit, Johannes W. A., Betty Weert, A. H. Schinkel, & Dirk Meijer. (1997). Transfection of polarized kidney epithelial cells with the mdr1a, mdr1b or mdr1 gene induces vectorial transmembrane transport of type1 and type2 organic cations.. Data Archiving and Networked Services (DANS). 1 indexed citations
13.
Groothuis, G M, et al.. (1995). Comparison of human hepatocytes isolated from livers accepted or discarded for orthotopic transplantation. Toxicology in Vitro. 9(6). 951–958. 15 indexed citations
14.
Weert, Betty, et al.. (1994). Characterization of transport in isolated human hepatocytes. Biochemical Pharmacology. 47(12). 2193–2200. 61 indexed citations
15.
Weert, Betty, et al.. (1990). Preservation of isolated rat and human hepatocytes in UW solution.. PubMed. 22(5). 2204–5. 10 indexed citations
16.
Braakman, Ineke, et al.. (1989). Vesicular uptake system for the cation lucigenin in the rat hepatocyte.. Molecular Pharmacology. 36(4). 537–542. 19 indexed citations
17.
Weert, Betty, et al.. (1988). Mechanisms for the hepatic uptake of organic cations. Studies with the muscle relaxant vecuronium in isolated rat hepatocytes.. Journal of Pharmacology and Experimental Therapeutics. 244(1). 268–275. 42 indexed citations
18.
Meijer, Dirk K. F., Betty Weert, & G. A. Vermeer. (1988). Pharmacokinetics of biliary excretion in man. VI. Indocyanine green. European Journal of Clinical Pharmacology. 35(3). 295–303. 94 indexed citations
19.
Weert, Betty, et al.. (1981). Isolation and analytical aspects of Valeriana compounds. Pharmacy World & Science. 3(1). 810–814. 2 indexed citations
20.
Weert, Betty, et al.. (1979). Isolation and analytical aspects of Valeriana compounds. Pharmacy World & Science. 1(1). 956–964. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026